Key stats
Fund info
Home page
Inception date
Aug 13, 2021
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Primary advisor
CI Investments, Inc.
ISIN
CA12567E1097
CUSIP
12567E109
FIGI
BBG01237LVC0
Identifiers
ISIN CA12567E1097
The fund specifically represents the healthcare space within developed markets. It includes companies engaged in medical distributions, hospital/nursing management and services, pharmaceuticals, biotech, drugstore chains, and other medical specialties. Eligible securities are ranked by market-cap, and the top 135 securities are selected for inclusion with considerations to succeeding ranks until the portfolio reaches 150 constituents. Holdings are market-cap-weighted and are rebalanced on a quarterly basis. The fund may include firms of all sizes, however, its market-cap-focused strategy skews the fund towards large-caps.
Classification
What's in the fund
Exposure type
Health Technology
Breakdown by region
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
CHCL.B trades at 26.44 CAD today, its price has risen 0.53% in the past 24 hours. Track more dynamics on CHCL.B price chart.
CHCL.B net asset value is 26.38 today — it's fallen 0.51% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
CHCL.B assets under management is 135.63 M CAD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
CHCL.B price has fallen by −1.56% over the last month, and its yearly performance shows a 12.51% increase. See more dynamics on CHCL.B price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.51% over the last month, have fallen by −0.51% over the last month, showed a −0.26% decrease in three-month performance and has increased by 13.97% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −0.51% over the last month, have fallen by −0.51% over the last month, showed a −0.26% decrease in three-month performance and has increased by 13.97% in a year.
CHCL.B fund flows account for 39.55 M CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
CHCL.B invests in stocks. See more details in our Profile section.
CHCL.B expense ratio is 0.56%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, CHCL.B isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, CHCL.B technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating CHCL.B shows the buy signal. See more of CHCL.B technicals for a more comprehensive analysis.
Today, CHCL.B technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating CHCL.B shows the buy signal. See more of CHCL.B technicals for a more comprehensive analysis.
CHCL.B trades at a premium (0.23%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
CHCL.B shares are issued by CI Financial Corp.
CHCL.B follows the Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Aug 13, 2021.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.